公司控股股东 WINWIN 于 2025 年 5 月 30 日收到询价转让资金 2.28 亿元， 缴纳相关税费后，剩余资金约为 2.03 亿元。WINWIN 将剩余资金无偿借予公司 使用，其中 1 亿元为短期借款，借款期限为一年，已于 2025 年 6 月 30 日划转 至公司账户，另外 1.03 亿元为中长期借款，借款期限为两年，公司按照相关要 求办理中长期外债备案登记后，近日款项已划转至公司账户。 | 证券代码：688678 | 证券简称：福立旺 | 公告编号：2025-058 | | --- | --- | --- | | 转债代码：118043 | 转债简称：福立转债 | | 福立旺精密机电(中国)股份有限公司 关于收到控股股东向公司提供的无息借款公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责 任。 综上，公司控股股东 WINWIN 本次询价转让扣除税费后实际所得的资金已 全部借予公司。 特此公告。 福立旺精密机电(中国)股份有限公司 为满足公司日常生产经营的资金需求，公司控股股东 WINWIN OVERSEAS ...

Core Viewpoint - Fuliwang Company is expected to report a significant decline in net profit for the first half of 2025, with projections indicating a loss of approximately 17 million yuan, representing a year-on-year decrease of about 137.12% [1][2]. Financial Performance - The net profit attributable to the parent company for the same period last year was approximately 45.8 million yuan, with a net profit excluding non-recurring gains and losses of about 35.1 million yuan, resulting in an earnings per share of 0.19 yuan [2]. - For the first half of 2025, the company's main business revenue is estimated to be around 557 million yuan, reflecting a year-on-year growth of approximately 10%. However, the main business costs increased by about 87 million yuan, a year-on-year rise of approximately 24% [2]. Operational Challenges - The decline in performance is attributed to two main factors: the underproduction of the subsidiary Nantong Fuliwang, which incurred a loss of about 31.9 million yuan due to high depreciation and labor costs, and the increased operational costs associated with preparing for the demand from a major North American client [2]. - The company is anticipating a release of production capacity in the third quarter to meet the demand for new headphone projects from a major North American client, suspected to be Apple's new AirPods [3]. Company Background - Fuliwang Company specializes in the research, design, production, and sales of various springs, connectors, automotive sunroof components, and other hardware accessories [9]. - The company reported a revenue of approximately 1.285 billion yuan in 2024, marking a year-on-year increase of 29.6%, while the net profit attributable to the parent company was about 54.5 million yuan, a decrease of 38.38% [9].

Core Viewpoint - The company, Fuliwang, anticipates a significant decline in net profit for the first half of 2025, projecting a loss of approximately 17 million yuan, which represents a year-on-year decrease of about 137.12% compared to the same period last year [1] Financial Performance - For the first half of 2025, the company's main business revenue is estimated to be around 557 million yuan, reflecting a year-on-year growth of approximately 10% [2] - The main business cost has increased by about 87 million yuan, a year-on-year rise of approximately 24%, primarily due to the recruitment of production personnel and equipment purchases to meet the demands of a new headphone project for a North American client [2] - The net profit attributable to shareholders has been declining for two consecutive years, with figures of 162 million yuan, 88.49 million yuan, and 54.53 million yuan for the years 2022, 2023, and 2024 respectively [2] Operational Challenges - The subsidiary, Nantong Fuliwang, has not yet fully commenced production, leading to significant expenses in depreciation and labor costs, resulting in a loss of approximately 31.9 million yuan for the first half of 2025 [1] - The company is preparing to ramp up production capacity in the third quarter to meet the anticipated demand for consumer electronics and orders from a major North American client [1] Historical Financial Data - The company's financial data for 2024 shows a revenue of approximately 1.29 billion yuan, a 29.6% increase from 2023, while the net profit attributable to shareholders decreased by 38.38% [3] - The net profit excluding non-recurring gains and losses also saw a significant decline of 47.51% compared to the previous year [3] Fundraising Activities - Fuliwang raised a total of 1.48 billion yuan since its listing, with the initial public offering (IPO) raising 782.47 million yuan, exceeding the original plan by 169.19 million yuan [4][6] - The company also issued convertible bonds totaling 700 million yuan, with a significant portion allocated to existing shareholders [5]

Group 1 - The company expects a net profit attributable to shareholders of approximately -17 million yuan for the first half of 2025, a decrease of 62.5% compared to the same period last year [1][2] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is approximately -25 million yuan, representing a decrease of 171.23% year-on-year [1][2] - The previous year's net profit attributable to shareholders was 45.8 million yuan, with a net profit of 35.1 million yuan after deducting non-recurring gains and losses [2] Group 2 - The primary reason for the performance change is the significant increase in costs, with Nantong Fuliwang incurring a loss of approximately 31.9 million yuan during the reporting period [2] - Operating costs increased by approximately 87 million yuan, a year-on-year growth of about 24%, mainly due to the recruitment of production personnel and equipment purchases to meet the order demands of a new headphone project for a North American client [3]

Group 1 - Liu Pharmaceutical Group plans to repurchase shares worth between 100 million and 200 million yuan, with a maximum repurchase price of 25.70 yuan per share [1] - Dongshan Precision intends to invest up to 1 billion USD to build a high-end printed circuit board project to meet the long-term demand for high-end printed circuit boards in emerging scenarios such as AI [1] - Bomaike reported a net profit of 12.39 million yuan for the first half of the year, a year-on-year decline of 80.42% [2] Group 2 - Western Mining achieved a net profit of 1.869 billion yuan in the first half of the year, a year-on-year increase of 15% [2] - Fuliwang expects a net loss of approximately 17 million yuan for the first half of the year, a decrease of 137.12% compared to the same period last year [2] - Digital Certification anticipates a net loss of between 80 million and 96 million yuan for the first half of the year, compared to a loss of 29.25 million yuan in the same period last year [3] Group 3 - Shanghai Construction reported a net profit of 710 million yuan for the first half of the year, a year-on-year decrease of 14.04% [5] - Funneng Co. achieved a net profit of 1.337 billion yuan in the first half of the year, a year-on-year increase of 12.48% [6] - Tengda Construction's total contract amount for the first half of the year decreased by 17.55% year-on-year [7] Group 4 - Fudan Fuhua decided to terminate the public transfer of a 28% stake in a subsidiary due to the lack of a deposit from potential buyers [9] - Fulei Ant's subsidiary has decided to cease operations due to intense competition in the photovoltaic industry and ongoing losses [11] - Dongfang Ocean's subsidiary received a medical device registration certificate for a folic acid testing kit [14] Group 5 - Huayu Pharmaceutical's subsidiary received overseas listing approvals for several products [16] - Feima International received a performance commitment compensation of 437 million yuan from its controlling shareholder [16] - Guangshen Railway signed a cooperation agreement for the Guangzhou East Station renovation project with a total investment of approximately 16.66 billion yuan [16] Group 6 - Anhui Construction won the bid for the S68 Jingde to Jixi Expressway project with an estimated total investment of 5.7 billion yuan [18] - China Communications Construction Company signed new contracts worth 991.054 billion yuan in the first half of the year, a year-on-year increase of 3.14% [19] - Kehui Co. plans to use up to 70 million yuan of idle funds for cash management [22] Group 7 - Biological Shares' subsidiary received a clinical trial approval for a cat mRNA vaccine, the first of its kind in China [23] - Ruipu Biological received a clinical trial approval for a pig mRNA vaccine, which is the first economic animal mRNA vaccine in China [24] - Nanjing New Hundred's major assets were judicially frozen due to liquidity debt crisis faced by its controlling shareholder [27] Group 8 - Changshu Bank plans to merge three village banks and establish branches, pending shareholder approval [28] - Yong'an Pharmaceutical plans to reduce its holdings by up to 2.6323 million shares [29] - Zhujiang Co. received approval from the Shanghai Stock Exchange for a stock issuance to specific targets [31] Group 9 - Sanyangma's subsidiary signed a 120 million yuan procurement contract for sensor products [33] - Jintou City Development plans to purchase a villa property for approximately 7.1854 million yuan [35] - Yuanli Co. intends to acquire 100% of Tongsheng Co. through a combination of cash and stock issuance [36] Group 10 - Xin'an Century's controlling shareholder plans to reduce holdings by up to 2.22% of the company's shares [36] - Fute Technology plans to raise up to 528 million yuan through a private placement for various projects [36] - Helen Piano's actual controller is set to change, with stock resuming trading [37] Group 11 - Weiergao expects a net profit increase of 12.55% to 30.87% for the first half of the year [38] - Saiwei Microelectronics plans to transfer up to 18% of its shares through an agreement [40] - Yongli Co. intends to acquire a 22.75% stake in a subsidiary [42] Group 12 - ST Xiachuang plans to publicly transfer a 20% stake in Guangdong Yuweiji [43] - Dema Technology's shareholders plan to transfer 778.84 million shares through an inquiry [45] - Zhongshi Technology's shareholders plan to reduce holdings by up to 2.86% of the company's shares [46] Group 13 - Wufang Optoelectronics' controlling shareholder plans to reduce holdings by up to 0.93% of the company's shares [48] - Fusenmei's chairman has been detained, temporarily unable to fulfill his duties [49] - Reliable Co.'s shareholders plan to reduce holdings by a total of up to 2.63% of the company's shares [51] Group 14 - Gao Neng Environment plans to repurchase shares worth between 100 million and 150 million yuan [53]

Financial Performance - The company expects a net profit attributable to shareholders of approximately -17 million yuan for the first half of 2025, a decrease of 62.80 million yuan or 137.12% compared to the same period last year [4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is expected to be around -25 million yuan, a decrease of 60.10 million yuan or 171.23% year-on-year [4]. - The previous year's net profit attributable to shareholders was 45.80 million yuan, with earnings per share of 0.19 yuan [6]. Reasons for Performance Decline - The main reason for the performance decline is the underproduction of the subsidiary Nantong Fulivang, which incurred a loss of approximately 31.90 million yuan in the first half of 2025 due to high depreciation and labor costs [7]. Revenue and Costs - The company's main business revenue for the first half of 2025 is approximately 557 million yuan, representing a year-on-year increase of about 10% [8]. - The main business costs increased by approximately 87 million yuan, a year-on-year increase of about 24%, primarily due to the recruitment of production personnel and equipment purchases to meet order demands [8]. Production Capacity and Market Demand - The company is preparing to release production capacity in the third quarter to meet the demand for consumer electronics and new headphone projects from major North American clients [7]. Financial Data and Risks - The financial data in this performance forecast has not been audited by registered accountants and is based on preliminary calculations by the company's finance department [5]. - The company has not identified any significant uncertainties that could affect the accuracy of this performance forecast as of the announcement date [9]. - Investors are advised to pay attention to investment risks as the forecast data is preliminary and the accurate financial data will be disclosed in the official half-year report [10].

Group 1 - Datang Power achieved a total on-grid electricity of approximately 123.99 billion kWh for the first half of 2025, a year-on-year increase of 1.30%, with wind and solar power generation increasing by 31.27% and 36.35% respectively [1] - North Self Technology signed an equipment procurement contract with a total amount of 164 million yuan [1] - Jinchuan Co. reported a net profit of 1.38 billion yuan for the first half of 2025, a year-on-year decrease of 8.45%, with operating revenue of 6.96 billion yuan, an increase of 5.55% [1][2] Group 2 - Microchip Biotech expects a revenue of 407 million yuan for the first half of 2025, a year-on-year increase of 35%, and a net profit of approximately 30.06 million yuan, a year-on-year increase of 173% [3] - Zongheng Co. anticipates a revenue of 135 million yuan for the first half of 2025, a year-on-year increase of 61.72%, with a net loss of 34.68 million yuan, reducing losses by 18.34 million yuan compared to the previous year [5] - Tuojing Technology expects a revenue of 1.21 billion to 1.26 billion yuan for the second quarter of 2025, a year-on-year increase of 52% to 58%, with a net profit of 238 million to 247 million yuan, a year-on-year increase of 101% to 108% [7] Group 3 - Star Power reported a net profit of 73.42 million yuan for the first half of 2025, a year-on-year decrease of 13.44%, with total revenue of 1.52 billion yuan, an increase of 13.70% [8] - Xiamen Tungsten reported a net profit of 972 million yuan for the first half of 2025, a year-on-year decrease of 4.41%, with operating revenue of 19.18 billion yuan, an increase of 11.75% [9] - Yikang Pharmaceutical's subsidiary received approval for clinical trials of YKYY029 injection for hypertension [11] Group 4 - Mould Technology received a project designation for luxury car exterior parts, with an expected total sales of 2.044 billion yuan over a five-year lifecycle [13] - Jinzhik Technology won multiple projects from the State Grid and Southern Power Grid, with a total bid amount of 133 million yuan [14] - Changjiang Media plans to use up to 700 million yuan of idle funds to purchase financial products [16] Group 5 - Ningbo Gaofa plans to invest up to 20 million USD to establish a production base in Morocco [20] - Xuantai Pharmaceutical's subsidiary received EU GMP certification for solid dosage production lines [22] - Changhua Group received a project designation for key metal structural components from a domestic new energy vehicle company, with an expected total sales of 235 million yuan over a four-year lifecycle [23]

Meeting Overview - The shareholders' meeting of Fuliwang Precision Electromechanical (China) Co., Ltd. was held on July 16, 2025, with a total of 155 ordinary shareholders present, holding 113,585,222 voting rights, which accounts for 43.81% of the company's total voting rights [1][4]. Voting Results - All non-cumulative voting proposals were approved with a high majority, including: - 99.89% approval for the first proposal with 113,466,194 votes in favor [2]. - 99.91% approval for the second proposal with 113,483,794 votes in favor [1][2]. - 99.91% approval for the third proposal with 113,483,794 votes in favor [1][2]. - Cumulative voting results indicated that candidates for the fourth board of directors were elected with significant support, including independent directors [3][4]. Legal Compliance - The meeting's procedures, including the convening and voting processes, were confirmed to be in compliance with the Company Law and the company's articles of association, ensuring the legality and validity of the meeting [4].

Group 1 - The legal opinion letter was issued by Grandall Law Firm (Suzhou) regarding the second extraordinary general meeting of shareholders of Fuliwang Precision Electromechanical (China) Co., Ltd. held in 2025 [1][2] - The meeting was convened by the company's board of directors based on a resolution from the 28th meeting of the third board of directors held on June 30, 2025 [2][3] - The notice for the meeting was published on the Shanghai Stock Exchange website on July 1, 2025, detailing the time, location, convenor, agenda, and registration methods [2][3] Group 2 - The meeting utilized a combination of on-site and online voting, with the on-site meeting held on July 16, 2025, at 14:00 [3][4] - A total of 155 participants attended the meeting, representing 113,585,222 shares, which accounted for 43.8097% of the total voting shares [5][6] - The qualifications of the convenor and attendees were verified to be in compliance with the Company Law and the company's articles of association [4][5] Group 3 - The voting procedures followed the requirements outlined in the meeting notice, with results collected from both on-site and online votes [6][12] - The resolutions passed during the meeting included significant support, with votes in favor reaching as high as 99.9107% for various proposals [6][10] - The voting results indicated that the resolutions met the necessary thresholds for both special and ordinary resolutions as per legal requirements [11][12]

Group 1 - The company will initiate the board of directors' re-election process on June 30, 2025, with a second extraordinary shareholders' meeting scheduled for July 16, 2025, to approve relevant proposals [1] - The fourth board of directors will consist of seven members, including one employee director elected by the employee representative assembly [1] - Chen Xiuping has been elected as the employee director and will serve alongside the other six directors elected at the extraordinary shareholders' meeting [1] Group 2 - Chen Xiuping's career includes roles as Deputy Manager of the Information Department from January 2018 to December 2019, and currently as Manager of the Information Department since January 2020 [3] - Chen Xiuping has no shareholding in the company and has no relationships with major shareholders or other board members [3] - Chen Xiuping meets the qualifications as per the Company Law of the People's Republic of China and the company's articles of association [3]